Now you can Request Appointments, Complete Patient Registration Forms, Make Payments and send Community Eye Center Secured Messages through “My Online Clinic.” You may Register or Log In... Here.


 Sunil Malkani, M.D.Sunil M. Malkani, M.D., is a Retinal Surgeon specializing in the treatment of macular degeneration, diabetic retinopathy and other diseases of the retina.

Sunil M. Malkani, M.D., renowned vitreoretinal specialist, is a graduate of the Wake Forest School of Medicine and a former Assistant Professor of Ophthalmology at the University of Florida. He is a talented surgeon with particular expertise in treating diabetic retinopathy, macular degeneration, epiretinal membranes, retinal detachments, macular holes, and other diseases of the retina. Currently involved in macular degeneration and diabetic retinopathy research, Dr. Malkani has published his work in ophthalmic journals and presented his work at national conferences. Born and raised in Nashville, Tennessee, Dr. Malkani enjoys playing tennis and spending time with his wife and son.






Education & Training

  • Assistant Professor, Univ. of Florida, Dept. of Ophthalmology
  • Fellowship in Vitreoretinal Diseases and Surgery
  • University of Florida
  • Residency, University of South Carolina
  • Internship, University of South Carolina
  • Doctor of Medicine, Wake Forest University School of Medicine
  • Bachelor of Arts, the University of North Carolina at Chapel Hill

Honors & Awards

  • Chief Resident, University of South Carolina, Department of Ophthalmology
  • Honors in Ophthalmology and Ophthalmic Research, Wake Forest University School of Medicine

Professional Affiliations

  • American Medical Association
  • American Academy of Ophthalmology
  • Lee County Medical Association
  • Collier County Medical Association
  • Florida Medical Association

Research & Publications

  • The investigator for rhuFab V2 (Genentech) in the treatment of macular degeneration.
  • Investigator for Immusol Phase II Clinical Trial of VIT 100 in the prevention of PVR following retinal detachment surgery.
  • Numerous presentations and exhibits at the Academy of Ophthalmology, The Association for Research in Vision and Ophthalmology, and the International Society of Ocular Toxicology.